ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Workshop Calls For Improved Surgical Oncology Training Programs

December 2, 1983

National Cancer Act; White House announces Three Cancer Initiatives

November 1, 1996

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

Bristol To Support Grants For Studies On Drug Resistance

June 26, 1987

Cigarette Smoking Linked With Cervical Cancer

April 13, 1984

NCI Advisory Group, Other Cancer Meetings

August 16, 1985